Overview: Weekly update of scientific breakthroughs in drug discovery, with emphasis on pre-clinical research, R&D trends, and pharmacogenomics.
Newsletter Subscribers: 35,000+
Publishing Schedule: weekly
Audience: Research scientists, lab supervisors, principal investigators and others involved in the field of human drug development.
Past Advertisers Include: Ajinomoto AminoScience, Applied Biosystems, National Cancer Institute, Carestream Molecular Imaging, BellBrook Labs, Diaclone, ScienceCareers
Reader Demographics
64% of FierceBioResearcher subscribers have recommended FierceBioResearcher to a friend or colleague
Company Type
Emerging & Mid-Tier Biotech/Pharma - 25%
Large Pharma - 6%
Clinical/Contract Research Organization (CRO) - 6%
Service/Supply/Manufacturing - 9%
Diagnostic & Device - 5%
Academic - 13%
Gov't, Non-Profit - 6%
Other - 30%
Job Function
Executive Management - 25%
Research & Development - 33%
Sales & Marketing - 6%
Business Development - 13%
Finance, Investment - 5%
Student - 1%
Other - 17%
Buying Authority
Lab Supplies & Equipment - 59%
Outsourcing Partners - CROs - 37%
Outsourcing Partners - other - 44%
IT/Software - 35%
Legal/Patent Services - 26%
Financial/Accounting Services - 17%
Enter your contact information to see current rates and packages.
Top Companies Represented
Abbott Bioresearch
Amgen
Allergan
Applied Biosystems
Array Biopharma
AstraZeneca
Biogen Idec
Boehringer Ingelheim
Bristol-Myers Squibb
Centocor
Cephalon
Charles River Laboratories
Columbia University
Covance
Elan Pharmaceuticals
Eli Lilly
EnVivo Pharmaceuticals
Exelixis
Fisher Scientific
Genentech
Genzyme
GlaxoSmithKline
Harvard Medical School
Health Advances
Invitrogen
Johnson & Johnson
Lexicon Genetics
Medarex
MedImmune
Merck & Co.
Millipore
NIH
Pfizer
Roche
Sanofi-Aventis
Stanford University
Theravance, Inc.
Wyeth Research
